Tailored Prediabetes Treatment: A New Approach to Preventing Type 2 Diabetes
More than 115 million Americans have prediabetes, but an estimated 80% are unaware of their condition. Recent research highlights the need for earlier, more personalized interventions to prevent the progression to type 2 diabetes (T2D), particularly among young adults. A one-size-fits-all approach may not be effective and identifying those at highest risk is crucial for targeted treatment strategies.
Understanding Prediabetes
Prediabetes is defined by the American Diabetes Association (ADA) based on specific criteria: impaired fasting glucose (FBG) between 5.6–6.9 mmol/L (100–125 mg/dL), impaired glucose tolerance (IGT) with 2-hour plasma glucose (PG) during a 75g oral glucose tolerance test (OGTT) of 7.8–11.0 mmol/L (140–199 mg/dL), or an HbA1c of 39–47 mmol/mol (5.7–6.4%) 1. It’s a prevalent condition, affecting 34.5% of U.S. Adults in 2018 1, and carries a substantial risk of developing T2D and cardiovascular disease.
Why a Personalized Approach is Key
New studies indicate that the risk of developing T2D varies significantly among adults aged 18 to 40 with prediabetes. Those with high fasting glucose levels, specifically those who meet the criteria for treatment with glucagon-like peptide 1 receptor agonist (GLP-1RA) medications, face a significantly higher risk of progressing to T2D within five years 3. This suggests that tailored interventions, rather than a universal approach, may be most beneficial.
GLP-1 Receptor Agonists: A Potential Treatment Option
GLP-1RAs have demonstrated benefits in managing blood glucose and promoting weight loss in individuals with T2D and/or obesity 2. Research is now exploring their efficacy for new indications, including prediabetes. However, medications like GLP-1s, if approved for prediabetes, would likely need to be taken indefinitely to maintain weight loss and ward off T2D and cardiovascular disease 1.
Risk Factors and Early Detection
The lifetime risk of progressing from prediabetes to T2D is substantial, reaching 74.0% in those aged 45 years 1. Early diagnosis is crucial, as nearly 90% of those with prediabetes are unaware they have it 1.
Lifestyle Interventions Remain Crucial
Even as medications may play a role, lifestyle modifications remain a cornerstone of prediabetes management. These include adopting a healthy diet, engaging in regular exercise, prioritizing solid sleep, and managing stress. These steps can help prevent or delay the development of T2D and its associated complications, such as heart disease, kidney disease, and stroke.
Looking Ahead
The current research emphasizes the need for improved detection of prediabetes and a shift towards more personalized treatment strategies. Further investigation is warranted to determine the optimal interventions for different risk profiles, ultimately aiming to prevent the progression to T2D and improve long-term health outcomes.